We are live on ! Find out more
AIP

Arrowpoint Investment Partners Portfolio holdings

AUM $459M
1-Year Est. Return 93.97%
This Fund
S&P 500
This Quarter Est. Return
+33.31%
1 Year Est. Return
+93.97%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$459M
AUM Growth
+$347M
Cap. Flow
+$245M
Cap. Flow %
53.32%
Top 10 Hldgs %
63.7%
Holding
167
New
86
Increased
23
Reduced
20
Closed
38

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$30.6M
2
GS icon
Goldman Sachs
GS
+$30.2M
3
XOM icon
ExxonMobil
XOM
+$26.8M
4
GPN icon
Global Payments
GPN
+$26.4M
5
NVDA icon
NVIDIA
NVDA
+$25.8M

Top Sells

Rank Stock Value
1
ASX icon
ASE Group
ASX
+$3.89M
2
ASND icon
Ascendis Pharma A/S
ASND
+$2.71M
3
IONS icon
Ionis Pharmaceuticals
IONS
+$2.01M
4
PFE icon
Pfizer
PFE
+$2M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.93M

Sector Composition

Rank Sector Weight
1 Miscellaneous 28.72%
2 Healthcare 18.58%
3 Financials 14.08%
4 Industrials 12.67%
5 Technology 12.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EWT icon
51
iShares MSCI Taiwan ETF
EWT
$12.2B
$1.21M 0.26%
11,100
-1,400
-11% -$131K
RVMD icon
52
Revolution Medicines
RVMD
$45B
$1.14M 0.25%
6,100
-1,871
-23% -$273K
MRNA icon
53
Moderna
MRNA
$58.1B
$1.04M 0.23%
14,841
-2,256
-13% -$117K
BBIO icon
54
BridgeBio Pharma
BBIO
$14.6B
$1M 0.22%
13,454
+7,669
+133% +$537K
IONS icon
55
Ionis Pharmaceuticals
IONS
$9.65B
$978K 0.21%
12,338
-26,650
-68% -$2.01M
XLU icon
56
State Street Utilities Select Sector SPDR ETF
XLU
$22.2B
$943K 0.21%
20,800
+4,400
+27% +$199K
QQQM icon
57
Invesco NASDAQ 100 ETF
QQQM
$105B
$939K 0.2%
+3,100
New +$878K
XLRE icon
58
State Street Real Estate Select Sector SPDR ETF
XLRE
$8.27B
$881K 0.19%
+20,000
New +$879K
PRAX icon
59
Praxis Precision Medicines
PRAX
$9.82B
$824K 0.18%
2,461
-1,394
-36% -$441K
NTRA icon
60
Natera
NTRA
$47.3B
$764K 0.17%
2,814
-156
-5% -$33.3K
CYTK icon
61
Cytokinetics
CYTK
$10.1B
$753K 0.16%
8,836
+1,448
+20% +$104K
TLT icon
62
iShares 20+ Year Treasury Bond ETF
TLT
$46.6B
$752K 0.16%
8,700
+1,600
+23% +$137K
KRE icon
63
State Street SPDR S&P Regional Banking ETF
KRE
$4.22B
$749K 0.16%
+10,000
New +$700K
ACAD icon
64
Acadia Pharmaceuticals
ACAD
$4.83B
$727K 0.16%
+28,725
New +$632K
WDC icon
65
Western Digital
WDC
$169B
$723K 0.16%
+1,132
New +$550K
XHB icon
66
State Street SPDR S&P Homebuilders ETF
XHB
$1.34B
$693K 0.15%
+6,000
New +$629K
BNTX icon
67
BioNTech
BNTX
$26.1B
$679K 0.15%
7,301
+411
+6% +$38.7K
LEGN icon
68
Legend Biotech
LEGN
$4.19B
$626K 0.14%
+21,669
New +$584K
KIE icon
69
State Street SPDR S&P Insurance ETF
KIE
$604M
$610K 0.13%
+10,000
New +$573K
ORKA
70
Oruka Therapeutics
ORKA
$6.13B
$601K 0.13%
6,315
+1,168
+23% +$77.8K
FLTW icon
71
Franklin FTSE Taiwan ETF
FLTW
$3.86B
$591K 0.13%
5,600
+1,900
+51% +$173K
UTHR icon
72
United Therapeutics
UTHR
$20.9B
$561K 0.12%
1,035
+508
+96% +$286K
XLF icon
73
State Street Financial Select Sector SPDR ETF
XLF
$55.5B
$515K 0.11%
9,600
+3,400
+55% +$177K
XLK icon
74
State Street Technology Select Sector SPDR ETF
XLK
$122B
$495K 0.11%
2,600
+2,400
+1,200% +$410K
ARWR icon
75
Arrowhead Research
ARWR
$12.2B
$442K 0.1%
+5,427
New +$401K
1 2
3
4 5

Similar funds

VIM
VELA Investment Management New Albany, Ohio $459M AUM 18.61% 1-Year Est. Return
AM
Atwater Malick Lancaster, Pennsylvania $459M AUM 37.25% 1-Year Est. Return
SSC
Syverson Strege & Co West Des Moines, Iowa $459M AUM 27.74% 1-Year Est. Return
RFN
RDA Financial Network Akron, Iowa $459M AUM 24.58% 1-Year Est. Return
PWS
Peterson Wealth Services South Ogden, Utah $459M AUM 42.99% 1-Year Est. Return
GCM
G2 Capital Management Columbus, Ohio $459M AUM 18.56% 1-Year Est. Return
CIM
Coleford Investment Management Toronto, Ontario, Canada $459M AUM 23.79% 1-Year Est. Return
RAG
RIA Advisory Group Des Moines, Iowa $460M AUM 29% 1-Year Est. Return

Arrowpoint Investment Partners's Q2 2026 Portfolio in Review

As of Q2 2026, Arrowpoint Investment Partners held 167 positions worth $459M, up 308% from $113M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Arrowpoint Investment Partners deployed $245M of net new capital in Q2 2026, opening 86 new positions and adding to 23 existing holdings. Its largest new stake was Citigroup: 235,033 shares worth $32.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, down from 45% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $2.01M trimmed.

  • Arrowpoint Investment Partners's largest Q2 2026 buy was Citigroup: 235,033 shares worth $32.9M.
  • Arrowpoint Investment Partners added most to Insmed in Q2 2026, an estimated $2.8M increase.
  • Arrowpoint Investment Partners's biggest Q2 2026 reduction was Ionis Pharmaceuticals, cutting an estimated $2.01M.
  • Arrowpoint Investment Partners fully exited ASE Group in Q2 2026, selling an estimated $3.89M.
  • Arrowpoint Investment Partners's ten largest holdings make up 64% of its $459M portfolio in Q2 2026.
  • Arrowpoint Investment Partners opened 86 new positions and closed 38 in Q2 2026.
  • Arrowpoint Investment Partners's portfolio value rose 308% quarter-over-quarter to $459M.

Based on Arrowpoint Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.